Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Established Scleroderma Renal Crisis
2005-000701-61Phase 2Completed
- Sponsor
- University College London
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bosentan in scleroderma renal crisis (SRC), sponsored by University College London. Primary endpoint: Creatinine clearance change over time. Started Oct 2005; status: completed.
02
Drugs
bosentan
03
Conditions
scleroderma renal crisis (SRC)
Beyond the preview
Go deeper on 2005-000701-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000701-61.